X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Thumbnail
AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its... [Read More]
Thumbnail
AstraZeneca's resumption of its COVID-19 vaccine trial puts health officials at UW Health and the UW School of Medicine and Public Health back in action... [Read More]
AstraZeneca Plc said on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20% of manufacturing costs to... [Read More]
Drugmakers AstraZeneca and Johnson & Johnson both said Friday they are set to resume their paused coronavirus vaccine trials in the United States after health... [Read More]
The Oxford-AstraZeneca vaccine will resume testing in the U.S. [Read More]
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.Testing of AstraZeneca's vaccine candidate had been halted since early September, while... [Read More]
AstraZeneca announces they are resuming COVID-19 vaccine trials in the United States, including trials at UW Health and the UW School of Medicine and Public... [Read More]
The Food and Drug Administration gives the pharmaceutical companies the green light to restart. [Read More]
By Maggie Fox and Jamie Gumbrecht, CNN Drugmakers AstraZeneca and Johnson & Johnson both said Friday they are set to resume their paused coronavirus vaccine... [Read More]
AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its... [Read More]
AstraZeneca has resumed the U.S. trial of its experimental Covid-19 vaccine after approval by U.S. regulators, and an oversight panel has recommended that Johnson &... [Read More]
COVID-19 vaccine candidates. [Read More]
AstraZeneca and Johnson & Johnson will continue their late-stage coronavirus vaccine trials in the US... [Read More]
Stocks shrugged off a sluggish start and ended mostly higher on Wall Street today. The S&P rose 11.90 points or 0.3% to 3,465.39, it's second... [Read More]
AstraZeneca, J&J vaccine trials back on track in US... [Read More]
AstraZeneca announced on Friday that the Food and Drug Administration (FDA) has allowed the company to restart its phase 3 COVID-19 vaccine trial in the... [Read More]
AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its... [Read More]
Dr. Scott Gottlieb, Former FDA Commissioner, joins 'Closing Bell' to talk about J&J and AstraZencea restarting its phase 3 Covid-19 vaccine trials. [Read More]
AstraZeneca Inc. announced Friday that regulators are letting it resume testing of its COVID-19 vaccine candidate in the U.S. Testing of the vaccine... [Read More]
Some of the AstraZeneca trials in the United States had been taking place at Indiana University School of Medicine in Indianapolis until they were paused... [Read More]
Loading...
Save As
Preview
Preview